Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
종목 코드 BMRA
회사 이름Biomerica Inc
상장일Mar 17, 1980
CEOMr. Zackary S. Irani
직원 수63
유형Ordinary Share
회계 연도 종료Mar 17
주소17571 Von Karman Avenue
도시IRVINE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호92614
전화19493792875
웹사이트https://biomerica.com/
종목 코드 BMRA
상장일Mar 17, 1980
CEOMr. Zackary S. Irani
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음